Number of the records: 1  

GCPII Variants, Paralogs and Orthologs

  1. 1.
    SYSNO ASEP0377922
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleGCPII Variants, Paralogs and Orthologs
    Author(s) Hlouchová, Klára (UOCHB-X) ORCID
    Navrátil, Václav (UOCHB-X) RID, ORCID
    Tykvart, Jan (UOCHB-X) RID, ORCID
    Šácha, Pavel (UOCHB-X) RID, ORCID
    Konvalinka, Jan (UOCHB-X) RID, ORCID
    Number of authors5
    Source TitleCurrent Medicinal Chemistry. - : Bentham Science Publishers - ISSN 0929-8673
    Roč. 19, č. 9 (2012), s. 1316-1322
    Number of pages7 s.
    Languageeng - English
    CountryNL - Netherlands
    KeywordsPSMA ; GCPIII ; NAALADase L ; splice variants ; homologs ; PSMAL
    Subject RIVCE - Biochemistry
    R&D ProjectsGAP304/12/0847 GA ČR - Czech Science Foundation (CSF)
    CEZAV0Z40550506 - UOCHB-X (2005-2011)
    UT WOS000300641400009
    DOI10.2174/092986712799462676
    AnnotationGlutamate carboxypeptidase II (GCPII) and its splice variants, paralogs and human homologs represent a family of proteins with diverse tissue distribution, cellular localization and largely unknown function which have been explored only recently. While GCPII itself has been thoroughly studied from different perspectives, as clearly documented in this series of reviews, very little is known about other members of its family, even though they might be biologically relevant. Differential expression of individual GCPII splice variants is associated with tumor progression and prognosis of prostate cancer. The best studied GCPII homolog, GCPIII or NAALADase II, may be a valid pharmaceutical target for itself since it may compensate for a lack of normal GCPII enzymatic activity. Detailed molecular characterization of this family of proteins is thus very important not only with respect to the potential therapeutic use of GCPII inhibitors, but also for better understanding of the biological role of GCPII within as well as outside the nervous system.
    WorkplaceInstitute of Organic Chemistry and Biochemistry
    Contactasep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418
    Year of Publishing2013
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.